MedPath

Comparative Evaluation of Two Sedatives in Pediatric Dental Procedure - A Randomized Clinical Trial

Phase 2/3
Completed
Conditions
Pulpitis,
Registration Number
CTRI/2022/02/040572
Lead Sponsor
Narsinhbhai Patel Dental College and Hospital
Brief Summary

This study is randomized controlled trial to compare  the effectives of  Midazolam and Dexmedetomidine as Sedative and Anxiolytic agent during dental procedures among 4 to 9 year old children utilizing split mouth technique. It would be conducted in Department of Pediatric and Preventive Dentistry at Narsinhbhai Patel Dental College & Hospital Visnagar Gujarat India. The primary outcome measures will be Dexmedetomidine is a better anxiolytic and sedative agent than Midazolam  in children during dental procedures. The secondary outcome measures will be Intranasal Dexmedetomidine is more effective than Intranasal Midazolam.

| |

| --- |

|

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Patients undergoing treatment for the first time.
  • Patient who exhibit anxious behavior in Frankel behavior rating scale ( score 1 & 2) Requiring two dental procedures under local anaesthesia.
Exclusion Criteria
  • Patients who do not exhibit anxious behaviour on baseline anxiety scale.
  • Patients with any systemic disease or drug allergy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Dexmedetomidine is a better anxiolytic and sedative agent than MidazolamBaseline, During procedure (45 mins) and After procedure (2 hours).
Secondary Outcome Measures
NameTimeMethod
Intranasal Dexmedetomidine is more effective than MidazolamBaseline, During procedure (45 mins) and After procedure (2 hours)

Trial Locations

Locations (1)

Narsinhbhai Patel Dental College and Hospital

🇮🇳

Mahesana, GUJARAT, India

Narsinhbhai Patel Dental College and Hospital
🇮🇳Mahesana, GUJARAT, India
DR KAVYA SHAH
Principal investigator
7708535361
kavshah04@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.